The present study suggested that the therapeutic inhibition of mitochondrial activity, which is supported by stored carbon sources and by low mitochondrial ROS via high SOD2 expression, could effectively target starvation-resistant cells in RCC. Here, SOD2 is linked to renal cell carcinoma.